The Board of SciClone Pharmaceuticals (Holdings) Limited announced that Ms. Lin Shirley Yi-Hsien has been appointed as a member of the Audit Committee with effect from December 19, 2022. Ms. Lin Shirley Yi-Hsien currently is a non-executive Director of the Company.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
18.22 HKD | +0.11% | +1.00% | +30.89% |
18/04 | Sciclone Pharmaceuticals to Dispatch Privatization Documents by May 31 | MT |
01/04 | SciClone Pharmaceuticals Logs 31% Increase in 2023 Profit | MT |
EPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+30.89% | 1.42B | |
-2.61% | 89.08B | |
+3.55% | 40.9B | |
-14.40% | 32.25B | |
+55.89% | 25.14B | |
-15.96% | 15.39B | |
-15.50% | 11.91B | |
-41.29% | 11.89B | |
-11.75% | 11.64B | |
+7.87% | 9.03B |
- Stock Market
- Equities
- 6600 Stock
- News SciClone Pharmaceuticals (Holdings) Limited
- SciClone Pharmaceuticals Limited Appoints Lin Shirley Yi-Hsien as Member of the Audit Committee